> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pfizer Recalling Lots of Accuretic, Others
- URL: https://www.fdaweb.com/pfizer-recalling-lots-of-accuretic-others/
- Published: 2022-03-23T12:00:00.000Z
- Updated: 2026-09-14T17:37:46.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5151434

FDA says Pfizer is recalling six lots of Accuretic (quinapril HCl/hydrochlorothiazide) tablets, one lot of quinapril and hydrochlorothiazide tablets distributed as an authorized generic by Greenstone, and four lots of quinapril HCl/hydrochlorothiazide tablets also distributed by Greenstone. The recalls are due to the presence of a nitrosamine, N-nitroso-quinapril, above the acceptable daily level, according to an agency [statement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pfizer-voluntary-nationwide-recall-lots-accuretictm-quinapril-hclhydrochlorothiazide-quinapril-and?utm%5Fmedium=email&utm%5Fsource=govdelivery).

The products are indicated for treating hypertension.

The company says it is not aware of reports of adverse events that have been assessed to be related to the recall.